Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Interleukin 22 mediates interleukin 23-induced pathology in newborn mice by disrupting the function of pancreatic and intestinal cells

ABSTRACT: Interleukin 22 mediates interleukin 23-induced pathology in newborn mice by disrupting the function of pancreatic and intestinal cells

PROVIDER: PRJNA565398 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10116206.fastq.gz	Fastqsanger.gz
	SRR10116207.fastq.gz	Fastqsanger.gz
	SRR10116208.fastq.gz	Fastqsanger.gz
	SRR10116209.fastq.gz	Fastqsanger.gz
	SRR10116210.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Interleukin 22 mediates interleukin 23-induced pathology in newborn mice by disrupting the function of pancreatic and intestinal cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-09-14 | GSE137415 | GEO

newborn mice

Project description:newborn mice Raw sequence reads

| PRJNA1048552 | ENA

An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis.

Project description: Not available

| S-EPMC6257980 | biostudies-literature

The neuroinflammatory interleukin-12 signaling pathway drives Alzheimer's disease-like pathology by perturbing oligodendrocyte survival and neuronal homeostasis

Project description:Central in AD-related neuroinflammation is the proinflammatory interleukin-12 (IL-12)/IL-23 signaling pathway whose inhibition has been shown to attenuate pathology and cognitive defects in AD-like mice. In order to explore which cell types are involved in this neuroinflammatory cascade, we used single-nuclei RNA sequencing in AD-like APPPS1 mice lacking or harboring IL-12/IL-23 signaling.

2024-12-31 | GSE173242 | GEO

Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.

Project description: Not available

| S-EPMC7919730 | biostudies-literature

Interleukin-12 signaling drives Alzheimer's disease pathology through disrupting neuronal and oligodendrocyte homeostasis.

Project description: Not available

| S-EPMC12003168 | biostudies-literature

The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology

Project description:In Alzheimer’s disease (AD), sensome receptor dysfunction impairs microglial danger-associated molecular pattern (DAMP) clearance and exacerbates disease pathology. While extrinsic signals including interleukin-33 (IL-33) can restore microglial DAMP clearance, it remains largely unclear how the sensome receptor(s) is regulated and interacts with DAMP during phagocytic clearance. Here, we show that IL-33 induces VCAM1 in microglia, which promotes microglial chemotaxis toward amyloid-beta (Aβ) plaque-associated ApoE, and leads to Aβ clearance. We show that IL-33 stimulates a chemotactic state in microglia, characterized by Aβ-directed migration. Functional screening identified that VCAM1 directs microglial Aβ chemotaxis by sensing Aβ plaque-associated ApoE. Moreover, we found that disrupting VCAM1–ApoE interaction abolishes microglial Aβ chemotaxis, resulting in decreased microglial clearance of Aβ. In patients with AD, higher cerebrospinal fluid levels of soluble VCAM1 were correlated with impaired microglial Aβ chemotaxis. Together, our findings demonstrate that promoting VCAM1–ApoE-dependent microglial functions ameliorates AD pathology.

2023-07-18 | GSE208006 | GEO

Newborn calf microbiome

Project description:Newborn calf microbiome - 16S rRNA gene sequences

| PRJNA890307 | ENA

923 enhancer deletion newborn mouse

Project description:923 enhancer deletion newborn mouse

| PRJNA667049 | ENA

Interleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer's disease-like mice.

Project description: Not available

| S-EPMC7054677 | biostudies-literature